Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CALA | Calithera Biosciences, Inc. | Chief Financial Officer & Secretary | $2.56K | Jan 23, 2023 | ||
ANTX | AN2 Therapeutics, Inc. | Director | Jun 19, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|